Disparities in Access to Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk African American Kidney Transplant Patients
AAs were significantly less likely to leverage assistance programs or utilize personal resources to access valganciclovir. This disparity was partially explained by age, insurance status, and donor type. Despite this, CMV infection rates were similar between AA and non-AA cohorts.
Authors
- David J. Taber (ORCID: https://orcid.org/0000-0001-7273-4589)
- Erika Andrade
- Zaid Mesmar (ORCID: https://orcid.org/0000-0001-6218-5475)
- Courtney E. Harris (ORCID: https://orcid.org/0000-0003-4611-0670)
- Isabel K. Calimlim
- Shipra Reddy Bethi
Institutions
- Medical University of South Carolina (US)
- Jordan University of Science and Technology (JO)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1111/tid.14416
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00